Aurobindo Pharma Limited

NSE: AUROPHARMA · Healthcare · Pharmaceuticals · Market cap ₹1,06,750 Cr

₹1,855.30+51.30 (+2.84%)

· Prev close ₹1,804.00 · Volume 24.12 L · 52W ₹1,106–1,855

Day range for 9 Nov not in the price history yet · 8 Nov ₹1,798.10–1,816.10

Last 4 quarters: profit +16.6% on the 4 beforeShare price +9.7% in a month

Aurobindo Pharma › Financial health

Financial health

Loading selected research…

NSE: AUROPHARMA · Healthcare · Pharmaceuticals · Market cap ₹1,06,750 Cr

₹1,855.30+51.30 (+2.84%)

· Prev close ₹1,804.00 · Volume 24.12 L · 52W ₹1,106–1,855

Day range for 9 Nov not in the price history yet · 8 Nov ₹1,798.10–1,816.10

Last 4 quarters: profit +16.6% on the 4 beforeShare price +9.7% in a month

Aurobindo Pharma › Financial health

Current ratio Not in our data

Needs current assets and current liabilities from the latest annual balance sheet filed with the exchange.

189%124%77%113%158%

FY22FY23FY24FY25FY26

100%: all profit arrived as cash

Year	Operating cash	Net profit	Conversion
FY22	5,016	2,647	189%
FY23	2,387	1,928	124%
FY24	2,435	3,169	77%
FY25	3,925	3,486	113%
FY26	5,526	3,505	158%
FY22–26	19,289	14,735	131%

5,3392,8515,2866,6487,9427,4797,6768,234

Mar 21Mar 22Mar 23Mar 24Mar 25Sep 25Mar 26Sep 26

0.240.120.200.220.240.210.200.21

Mar 21Mar 22Mar 23Mar 24Mar 25Sep 25Mar 26Sep 26

Loading selected research…